RxDoctor Payments Data

John Steele, MD

Adult Reconstructive Orthopaedic Surgery · Towson, MDNPI 1881057131

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,838 of the $51,790 with a category attached, or 65.3%. Medical Device Business Services, Inc. accounts for 62.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $31,494, 2.3 times the $13,610 reported in 2022.

$51,790in general payments, 2019–2025

Across 70 payments — averaging $739.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$32K
  • Smith+Nephew$12K
  • Depuy Synthes Products, Inc.$6K
  • Johnson & Johnson$788
  • Stryker$558
  • C. R. Bard, Inc. & Subsidiaries$164
  • plus $292 from 4 others

What the payments were for

  • Consulting fees$33,83865%
  • Travel & lodging$2,9186%
  • Food & beverage$3,0356%
  • Education$12,00023%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,790 in reported general payments places this provider in the 80th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.

See all adult reconstructive orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$561,727
Medicare patients
871
Services billed
5,893

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib64$1,691
Methylprednisolone127$841
Mupirocin111$672
Meloxicam193$632
Doxycycline Hyclate13$183
Amoxicillin97$141
Gabapentin26$64
Clindamycin Hcl14$33

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Towson

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →